Parkemed
Recall
|
Medicines
|
05/04/2019
The marketing authorisation holder informed its customers on April 4, 2019 that there is a risk that "Parkemed - Suspension zur oralen Anwendung" will likely contain levels of Lead (Pb) and Lithium (Li) which exceed the Permitted Daily Exposure (PDE) levels. Therefore all batches within shelf-life are recalled as a precautionary measure.
| Name of the medicinal product | Parkemed - Suspension zur oralen Anwendung |
|---|---|
| Marketing authorisation number(s) | 13621 |
| Marketing authorisation holder | Pfizer Corporation Austria GmbH |
| Batch number(s) | 1609777, 1609778, 1703778, 1703724, 1706159, 1706160 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-2835 |
Further inquiry note
Page last modified:
07/11/2019